Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 2856 for cancer

Edit search filters
  1. Pembrolizumab In Treating Participants With Recurrent Ovarian Cancer

    Rochester, MN

  2. A Study To Evaluate The Safety And Effectiveness Of AB928-Based Treatment Combinations To Treat Patients With Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ

  3. MC200404, Safety And Immunogenicity Of PolyPEPI1018 Vaccine In The Treatment Of Late-stage Metastatic Colorectal Cancer

    Rochester, MN

  4. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer

    Rochester, MN

  5. Monitoring Symptoms To Help Young Women Take Hormone Therapy For Stage I-III Breast Cancer, ASPEN Study

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI

  6. Iodine I-131 With Or Without Selumetinib In Treating Patients With Recurrent Or Metastatic Thyroid Cancer

    Rochester, MN

  7. Study Of CG0070 Given In Combination With Pembrolizumab, In Non Muscle Invasive Bladder Cancer, Unresponsive To Bacillus Calmette-Guerin

    Rochester, MN

  8. Phase 2 Study To Evaluate Safety And Efficacy Of Cretostimogene Grenadenorepvec In NMIBC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Study Of RP-6306 With Gemcitabine In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Phase 1B/​2 Study Of RP1 In Solid Organ Transplant Patients With Advanced Cutaneous Malignancies (ARTACUS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer